Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

NCT05599984

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +20 more
Locations
  • Banner MD Anderson Cancer Ctr /ID# 260129 Gilbert, Arizona, United States
  • City Of Hope Comprehensive Cancer Center /ID# 271295 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 259884 Irvine, California, United States
  • Yale New Haven Hospital /ID# 246647 New Haven, Connecticut, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

NCT03122522

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Hartford Healthcare Alliance (Data Collection Only) Hartford, Connecticut, United States
  • Jaykumar Thumar Hartford, Connecticut, United States
  • JOHNS HOPKINS HOSPITAL (Data Analysis Only) Baltimore, Maryland, United States
  • Brigham and Women's Hospital (Data and Specimen Analysis Only) Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

NCT06068075

Conditions
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue, +19 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

NCT02176967

Conditions
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +10 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

NCT03491683

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University, School of Medicine Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 21 locations
View Trial Details

Related conditions